Shares of WellPoint Inc. partially recovered Friday morning after a plunge was touched off Thursday by gathering momentum behind health care reform and talk of a windfall-profit tax by Speaker of the House Nancy Pelosi.
The health reform bill sponsored by U.S. Sen. Max Baucus, D-Mont., would help pay for expanded health insurance coverage
by levying fees of $13 billion a year on the health care industry. The fees would deliver a hefty bill to just
about all of Indiana’s major health care companies. But how they’re reacting to the fees is all over the map.
The business park would encompass about 900 acres on the town’s northeast side and require rezoning
of much of the land, from residential and agriculture to commercial.
The new president of Community Hospital East says her job is all about health—the health of not just patients, but
the entire neighborhood.
Eli Lilly and Co. has agreed to settle the State of South Carolina’s lawsuit that claimed Lilly improperly marketed the antipsychotic
drug Zyprexa, according to Bloomberg News.
Fishers development officials hope to create a huge cluster of medical and research facilities near Interstate 69’s Exit
10, near St. Vincent Medical Center Northeast, but local real estate experts disagree about the amount of potential demand
for such a development.
Rolls-Royce, the British jet engine maker, isn’t taking a position on health care reform, but let’s drag them into it, anyway,
because Rolls-Royce’s business model might interest the crowd advocating for reform via market forces.
The Indiana Division of Aging wants to change Medicaid rates to nursing homes to reward quality care and penalize the lack
of it, leaving the industry divided over whether to support the groundbreaking rule or to seek revisions and a slower phase-in.
Six hospital systems, including three in Indiana, have agreed to pay the federal government $8.3 million to settle a whistleblower
lawsuit alleging the hospitals deliberately overcharged Medicare for routine back surgeries.
With its financial performance exceeding expectations, St. Francis Hospital & Health Centers will resume construction on a $265 million, 221-bed patient tower at its Indianapolis campus, the hospital system announced Thursday.
Most business groups cheered when Sen. Max Baucus, D-Mont., introduced a health reform bill with no so-called public option,
a controversial government-run insurance plan for working adults. But there’s a big group that would like
to see it back on the table—hospitals.
The tool the administration is using to measure waste shows that expenses in Indianapolis might be low enough
not to get whacked. But the region isn’t performing so well that it’s likely to get much praise, either.
Mead Johnson Nutrition plans to spend nearly $33 million at a southwestern Indiana facility where it plans to start making
powdered infant formula products.
Indianapolis-based Eli Lilly and Co. announced today that a clinical trial showed lung cancer patients treated with Lilly
drug Alimta lived about three months longer than those who received the best available care.
Medical equipment supplier Hill-Rom Holdings Inc. said yesterday it has begun a chief executive search to plan for the retirement
of current CEO Peter Soderberg.
Employees at five different companies collectively lost 805 pounds over six weeks this summer. They also
raised $805 for Big Brothers/Big Sisters of Central Indiana.
Where once we believed people were victims of disease, we now insist
that illness is a reflection of choices actively made.
Migraines cost American employers $20 billion a year in decreased worker productivity. Such
a frequent and uncured disease stands as a huge business opportunity for the health care industry, including locally based pharmaceutical giant Eli Lilly and Co.
Since John Lechleiter was named CEO 18 months ago, he’s bet that Eli Lilly and Co. could face down its looming patent challenges
by launching innovative new medicines. Today’s announcement of 5,500 job cuts by the end of 2011 and a restructuring of the
company’s business units ups the ante on that bet, while indicating that it isn’t working yet.
Eli Lilly and Co. has experienced a string of setbacks in recent years. Is it still a good place to work?
